熊胆开明片治疗青光眼睫状体炎综合征的近期疗效观察

发布时间：2018-12-31 14:23

【摘要】：目的探讨熊胆开明片治疗青光眼睫状体炎综合征(PSS)的临床疗效。方法就诊的青光眼睫状体炎综合征患者147例(165只眼),随机分为治疗组78例和对照组69例。西药常规治疗为对照组,治疗组在西药常规治疗的同时,加用熊胆开明片口服治疗,比较2组患者的平均视力,平均眼压的变化,KP消失情况疗效和治疗时间。结果治疗组的视力恢复时间明显缩短,眼压下降时间明显短于对照组,KP消失时间优于对照组,总好转率明显高于对照组,治疗时间治疗组短于对照组,差异均有统计学意义(P0.05)。结论应用熊胆开明片的中西医结合治疗PSS能更快速控制炎症、降低眼压,缩短疗程,提高有效率,减少复发,防止激素的不良反应的发生。
[Abstract]:Objective to investigate the clinical effect of Xiongdan enlightened tablet in the treatment of glaucoma ciliary syndrome (PSS). Methods 147 patients (165 eyes) with glaucoma ciliary syndrome were randomly divided into treatment group (n = 78) and control group (n = 69). The routine treatment of western medicine was used as control group, and the treatment group was treated with Xiong Gan Kian tablet at the same time. The mean visual acuity, the mean intraocular pressure, the effect of KP disappearance and the time of treatment were compared between the two groups. Results the recovery time of visual acuity in the treatment group was shorter than that in the control group. The time of KP disappearance was significantly shorter in the treatment group than in the control group. The total improvement rate in the treatment group was significantly higher than that in the control group, and the treatment time in the treatment group was shorter than that in the control group. The difference was statistically significant (P0.05). Conclusion the combination of traditional Chinese and western medicine with Xiong Dan Kaiqi tablet can control inflammation, reduce intraocular pressure, shorten the course of treatment, improve the effective rate, reduce recurrence and prevent the occurrence of adverse reaction of hormone more quickly.
【作者单位】：河北省石家庄市第一医院眼科;中国电子科技集团公司十三研究所职工医院;
【基金】：石家庄市科学技术研究与发展指导计划项目(编号:151460953)
【分类号】：R276.7

【参考文献】